Hepatocyte PIEZO1 Negatively Regulates Lipogenesis and Ameliorates MASLD by Sensing Membrane Tension and Activating AMPK
Authors:
Open Access
- 3 April 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (34) , e15847
Abstract
Liver is a central organ for lipid metabolism. Disruption of lipid homeostasis leads to lipid accumulation in hepatocytes, which is a feature of metabolic dysfunction‐associated steatotic liver disease (MASLD). Mechanical force and mechanosensitive proteins have been found to play a crucial role in energy metabolism. However, their role in hepatic lipid metabolism remains unclear. In this study, mechanosensitive ion channel PIEZO1 is detected in hepatocytes, and downregulated in the liver of MASLD patients and high‐fat diet (HFD)‐induced MASLD mouse model. Under HFD feeding, mice with hepatocyte‐specific Piezo1 deletion exhibit severer triglyceride accumulation, upregulation of de novo lipogenesis genes, and decreased phosphorylation of AMPK and RAPTOR in the liver. In contrast, injection of PIEZO1 activator Yoda1 alleviates triglyceride accumulation, downregulates lipogenesis genes and enhances phosphorylation of AMPK and RAPTOR in HFD‐fed C57BL/6 mice. Knockdown of PIEZO1 in HepG2 leads to upregulation of lipogenesis genes and impairs AMPK‐RAPTOR pathway, while Yoda1 or hypotonic treatment do the reverse. The effects of PIEZO1 knockdown and Yoda1 treatment can be abolished by AMPK activator and CaMKK2/AMPK inhibitors, respectively. These findings suggest that PIEZO1 can respond to changes in membrane tension and activate AMPK, thereby inhibiting lipogenesis and maintaining lipid homeostasis.Keywords
Funding Information
- National Natural Science Foundation of China (82470904)
- National Natural Science Foundation of China (82570987)
- National Natural Science Foundation of China (82425010)
- National Natural Science Foundation of China (12372317)
- Natural Science Foundation of Guangdong Province (2023A1515012686)
- Natural Science Foundation of Guangdong Province (2024A1515012988)
- Key Technologies Research and Development Program (2024YFA1107200)
This publication has 46 references indexed in Scilit:
- Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1–YAP MechanotransductionAdvanced Science, 2026
- Mechanical regulation of lipid and sugar absorption by Piezo1 in enterocytesActa Pharmaceutica Sinica B, 2024
- A multisociety Delphi consensus statement on new fatty liver disease nomenclatureAnnals of Hepatology, 2023
- Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosisCurrent Biology, 2023
- Piezo1 alleviates acetaminophen-induced acute liver injury by activating Nrf2 and reducing mitochondrial reactive oxygen speciesBiochemical and Biophysical Research Communications, 2023
- Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathwayCell Calcium, 2021
- Mechanical Stiffness Controls Dendritic Cell Metabolism and FunctionCell Reports, 2021
- AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth ControlCell Metabolism, 2020
- Triglyceride Metabolism in the LiverComprehensive Physiology, 2018
- Lipid Metabolism and the Liver2016